Tadeusz Hawrot, Psychedelic Access and Research European Alliance (PAREA), describes ongoing clinical trials and research assessing the efficacy and safety of psychedelic-assisted therapies for the treatment of mental, neurological, and substance use disorders. Promising results are coming from studies looking at traumatic brain injury, post-traumatic stress disorder, and cluster headache. This interview took place at the European Academy of Neurology (EAN) 2022 Congress in Vienna, Austria.